MedTrace Logo

Atalante USAbility

NCT05284708 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-03-17

No results posted yet for this study

Summary

The "USAbility" study - Human Factor Validation Testing of the Atalante exoskeleton aims at demonstrating that Atalante can be used by the intended users without serious use errors or problems, for the intended uses and under the expected use conditions.

Conditions

  • Hemiplegia

Interventions

DEVICE

Atalante

Powered Exoskeleton

Sponsors & Collaborators

  • Innovative Medical Technologies, Inc

    collaborator OTHER

  • Shirley Ryan AbilityLab

    collaborator OTHER

  • Wandercraft

    lead INDUSTRY

Principal Investigators

  • Arun Jayaraman, PhD · Shirley Ryan AbilityLab

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-29
Primary Completion
2021-12-17
Completion
2022-01-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05284708 on ClinicalTrials.gov